Cargando…

Succinobucol-Eluting Stents Increase Neointimal Thickening and Peri-Strut Inflammation in a Porcine Coronary Model

OBJECTIVE: The aim of this study was to assess the efficacy of stent-based delivery of succinobucol alone and in combination with rapamycin in a porcine coronary model. Background: Current drugs and polymers used to coat coronary stents remain suboptimal in terms of long term efficacy and safety. Su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watt, Jonathan, Kennedy, Simon, McCormick, Christopher, Agbani, Ejaife O, McPhaden, Allan, Mullen, Alexander, Czudaj, Peter, Behnisch, Boris, Wadsworth, Roger M, Oldroyd, Keith G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Coronary Artery Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600531/ https://www.ncbi.nlm.nih.gov/pubmed/22581717 http://dx.doi.org/10.1002/ccd.24473

Ejemplares similares

Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021)

Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial
por: Buiten, Rosaly A., et al.
Publicado: (2020)

Comparison of neointimal coverage between ultrathin biodegradable polymer‐coated sirolimus‐eluting stents and durable polymer‐coated everolimus‐eluting stents: 6 months optical coherence tomography follow‐up from the TAXCO study
por: Abhyankar, Atul, et al.
Publicado: (2020)

Safety and efficacy of Everolimus‐Eluting bioabsorbable Polymer‐Coated stent in patients with long coronary lesions: The EVOLVE 48 study
por: Karmpaliotis, Dimitrios, et al.
Publicado: (2021)

Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent
por: Barkholt, Trine Ø., et al.
Publicado: (2019)

The relationship between re-endothelialization and endothelial function after DES implantation: Comparison between paclitaxcel eluting stent and zotarolims eluting stent
por: Murase, Suguru, et al.
Publicado: (2014)

One‐year clinical outcomes of patients treated with polymer‐free amphilimus‐eluting stents or zotarolimus‐eluting stents: A propensity‐score adjusted analysis
por: Rozemeijer, Rik, et al.
Publicado: (2019)

Five‐year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus‐eluting coronary stents with everolimus‐eluting bioresorbable vascular scaffolds
por: Schukraft, Sara, et al.
Publicado: (2021)

Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Polymer‐free Biolimus‐A9 coated thin strut stents for patients at high bleeding risk 1‐year results from the LEADERS FREE III study
por: Eberli, Franz R., et al.
Publicado: (2021)

Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent
por: Toelg, Ralph, et al.
Publicado: (2020)

Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Three‐year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus‐eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus‐eluting stent: A randomized controlled trial
por: Kim, Soo‐Hyun, et al.
Publicado: (2019)

Comparison of long‐term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus‐eluting stent or permanent polymer everolimus‐eluting stent: 5‐year results of the CENTURY II randomized clinical trial
por: Iñiguez, Andrés, et al.
Publicado: (2019)

Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials
por: Jackson-Smith, Elliot, et al.
Publicado: (2022)

Biological effect on drug distribution and vascular healing via paclitaxel‐coated balloon technology in drug eluting stent restenosis swine model
por: Li, Yan, et al.
Publicado: (2015)

Beta blockers versus calcium channel blockers for provocation of vasospastic angina after drug-eluting stent implantation: a multicentre prospective randomised trial
por: Sawano, Mitsuaki, et al.
Publicado: (2020)

Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study
por: Kerkmeijer, Laura S.M., et al.
Publicado: (2020)

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention
por: Krenn, Lisa, et al.
Publicado: (2014)

Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study
por: Ploumen, Eline H., et al.
Publicado: (2019)

Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention
por: Mangion, Kenneth, et al.
Publicado: (2016)

Cost‐effectiveness of percutaneous coronary intervention with cobalt‐chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta‐analysis of randomized trials
por: Ferko, Nicole, et al.
Publicado: (2016)

Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women: a pooled analysis of the BASKET-PROVE I and II trials
por: Bjerking, Louise Hougesen, et al.
Publicado: (2019)

Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trial
por: De Filippo, Ovidio, et al.
Publicado: (2020)

Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial
por: Hennigan, Barry, et al.
Publicado: (2020)

Comparison of 6‐month vascular healing response after bioresorbable polymer versus durable polymer drug‐eluting stent implantation in patients with acute coronary syndromes: A randomized serial optical coherence tomography study
por: Noguchi, Masahiko, et al.
Publicado: (2021)

Impact of proctoring on success rates for percutaneous revascularisation of coronary chronic total occlusions
por: Sharma, Vinoda, et al.
Publicado: (2015)

Sex-based associations with microvascular injury and outcomes after ST-segment elevation myocardial infarction
por: Maznyczka, Annette Marie, et al.
Publicado: (2019)

Sex differences in procedural and clinical outcomes following rotational atherectomy
por: Ford, Thomas J., et al.
Publicado: (2019)

Long-term Outcomes for Drug-eluting Balloons versus Drug-eluting Stents in the Treatment of Small Vessel Coronary Artery Disease: A Systematic Review and Meta-analysis
por: Murphy, Greg, et al.
Publicado: (2023)

Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis
por: Nørgaard, Bjarne L, et al.
Publicado: (2022)

Outcomes of patients with spontaneous coronary artery dissection
por: McGrath-Cadell, Lucy, et al.
Publicado: (2016)

Coronary perforation incidence, outcomes and temporal trends (COPIT): a systematic review and meta-analysis
por: Mikhail, Philopatir, et al.
Publicado: (2022)

Coenzyme Q10 deficiency can be expected to compromise Sirt1 activity
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Nutraceutical activation of Sirt1: a review
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Re-engineering the post-myocardial infarction medicines optimisation pathway: a retrospective analysis of a joint consultant pharmacist and cardiologist clinic model
por: Khatib, Rani, et al.
Publicado: (2018)

Effects of prehospital 12-lead ECG on processes of care and mortality in acute coronary syndrome: a linked cohort study from the Myocardial Ischaemia National Audit Project
por: Quinn, Tom, et al.
Publicado: (2014)

The Manchester Acute Coronary Syndromes (MACS) decision rule for suspected cardiac chest pain: derivation and external validation
por: Body, Richard, et al.
Publicado: (2014)

Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial
por: Adamson, Philip D, et al.
Publicado: (2018)

Differences in relative and absolute effectiveness of oral P2Y(12) inhibition in men and women: a meta-analysis and modelling study
por: Lee, Kuan Ken, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t2psdr51h0bsl0q4v75qu7p73n